We help companies optimise their vaccines’ antigenicity and immunogenicity by analysing millions of genomes of viruses and immunological and epidemiological data.
We started Deepflare with the goal of analysing genomes of SARS-CoV-2 and helping to develop. To achieve that, we developed an AI platform that analyses millions of viruses, predicts future variants, and quickly finds sequences to contain in a drug and vaccine.
.png)
